Clinical characteristics and molecular evolution of ST11-KL64 carbapenem-resistant hypervirulent Klebsiella pneumoniae co-producing KPC-2 and NDM-1 from China
Microbiology Spectrum · 03.03.2026 · 14 (3)
DOI: 10.1128/spectrum.02911-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 03.03.2026. Verfasst von Letian Xia und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, beta-Lactamases, Klebsiella Infections, Bacterial Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The emergence of carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKP), particularly strains co-producing dual carbapenemases such as Klebsiella pneumoniae carbapenemase (KPC) and New Delhi metallo-β-lactamase (NDM), poses a significant challenge in clinical settings. This study aimed to elucidate the clinical features, molecular epidemiology, virulence phenotype, and plasmid stability of ST11-KL64-type K. pneumoniae co-producing KPC-2 and NDM-1. We retrospectively analyzed 44 non-duplicate clinical isolates of KPC-2-NDM-1-carbapenem-resistant K. pneumoniae (K2N1-CRKP) and their corresponding clinical data from patients in a Chinese teaching hospital in 2021. Comprehensive analyses included antimicrobial susceptibility testing, pulsed-field gel electrophoresis (PFGE), whole-genome sequencing, serum killing assays, Galleria mellonella infection models, and plasmid stability experiments. All isolates were resistant to carbapenems and ceftazidime/avibactam. These strains belonged to the ST11-KL64-O1/O2v1 clone and showed high genetic relatedness (≥88% similarity) via PFGE. Among them, 79.55% (35/44) were classified as CR-hvKP, carrying the virulence genes iucABCD and rmpA / rmpA2 . Genomic analysis revealed that bla KPC-2 and bla NDM-1 were located on an IncFII/IncR plasmid and an untypable plasmid, respectively, while the virulence gene cluster was identified on an IncFIB/IncHI1B virulence plasmid. The virulence phenotypes of selected strains exhibited heterogeneity. One isolate (KP1225) demonstrated high virulence in vitro and in vivo . Notably, these strains maintained their resistance plasmids without antibiotic pressure (retention rate >85% after 10 days), with no significant fitness cost observed. This study reveals a clonal dissemination of ST11-KL64-K2N1-CR-hvKP, successfully integrating carbapenem resistance and hypervirulence with high genetic stability. The potential risk of its spread warrants urgent attention and effective infection control measures. IMPORTANCE The emergence of bacterial pathogens that combine hypervirulence with advanced antimicrobial resistance poses a significant challenge for modern healthcare. This study comprehensively analyzes a concerning clinical strain: ST11-KL64 K. pneumoniae co-harboring both KPC-2 and NDM-1 carbapenemases. We demonstrate that this strain successfully integrates multiple resistance mechanisms, hypervirulence determinants, and remarkable genetic stability without observable fitness costs—a combination that significantly complicates treatment and infection control. Critically, the stable maintenance of its resistance plasmids without antibiotic selection highlights the potential for persistent colonization and transmission. These findings underscore an evolving threat in the landscape of multidrug-resistant infections and emphasize the urgent need for enhanced surveillance, robust diagnostic approaches, and novel therapeutic strategies to address such challenging pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China.
- School of Medical Technology, Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China.
- Department of Medical Laboratory Technology, Feng Xian People's Hospital, Xuzhou, Jiangsu, People's Republic of China.
- Department of Clinical Laboratory, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China.
- The Center for Clinical Research and Transformation of Pathogen Diagnosis, Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China.
- School of Life Sciences, Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China.
ORCID-Profile: Letian Xia, Mengjiao Shi, Chenfei Li, Yaqi Zhu, Fei Jiang, Shulong Zhao, Shuang Song, Youzhen Ma, Lei Cheng, Haiquan Kang
Zitieren
APA
Xia, L., Shi, M., Li, C., Zhu, Y., Jiang, F., Zhao, S., Song, S., Ma, Y., Cheng, L., & Kang, H. (2026). Clinical characteristics and molecular evolution of ST11-KL64 carbapenem-resistant hypervirulent Klebsiella pneumoniae co-producing KPC-2 and NDM-1 from China. Microbiology Spectrum, 14(3). https://doi.org/10.1128/spectrum.02911-25
Vancouver
Xia L, Shi M, Li C, Zhu Y, Jiang F, Zhao S, et al. Clinical characteristics and molecular evolution of ST11-KL64 carbapenem-resistant hypervirulent Klebsiella pneumoniae co-producing KPC-2 and NDM-1 from China. Microbiology Spectrum. 2026;14(3). doi:10.1128/spectrum.02911-25
BibTeX
@article{Xia2026,
author = {Xia, Letian and Shi, Mengjiao and Li, Chenfei and Zhu, Yaqi and Jiang, Fei and Zhao, Shulong and Song, Shuang and Ma, Youzhen and Cheng, Lei and Kang, Haiquan},
title = {Clinical characteristics and molecular evolution of ST11-KL64 carbapenem-resistant hypervirulent Klebsiella pneumoniae co-producing KPC-2 and NDM-1 from China},
journal = {Microbiology Spectrum},
year = {2026},
volume = {14},
number = {3},
doi = {10.1128/spectrum.02911-25}
}
EUVIMED